Kristina Z.

Kristina Z. is an experienced scientist specializing in cell biology and cancer drug discovery. Since June 2018, Kristina has contributed to ADC Therapeutics, focusing on the development of Antibody Drug Conjugates (ADCs) for targeted cancer therapies. Prior to this role, Kristina worked at Centauri Therapeutics Limited from June 2017 to July 2018, where responsibilities included developing in vitro pharmacology and cell-based assays to evaluate novel agents, as well as designing and implementing immunological assays. Kristina's research experience also includes a position as a Visiting Researcher at the University of Westminster from February 2015 to June 2017, where work involved analyzing B-Chronic Lymphocytic Leukaemia samples through flow cytometry and microscopy. Academic credentials include a Master’s Degree in Immunology from King's College London and a Bachelor's Degree in Biomedical Science from the University of Westminster, both with commendable achievements.